Are two too many when it comes to the treatment of anal canal cancer with concurrent radiation and mitomycin C?

被引：0
|
作者：
Al Habsi, Zainab
Abraham, Aswin George
Al Balushi, Mustafa
Tankel, Gabriella
Mulder, Karen E.
Warkentin, Heather
Schiller, Dan E.
Tankel, Keith
Usmani, Nawaid
Severin, Diane
Paulson, Kim
Karachiwala, Hatim
Wong, Clarence K. W.
Nijjar, Tirath
Joseph, Kurian
机构：
[1] Cross Canc Inst, Edmonton, AB, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Univ Oxford, Oxford, England
[4] Univ Alberta Hosp, Cross Canc Inst, Edmonton, AB, Canada
[5] Univ Alberta, Edmonton, AB, Canada
[6] Cross Canc Inst, Edmonton, AB, Canada
[7] Cross Canc Inst, Edmonton, AB, Canada
[8] Univ Alberta, Cross Canc Inst, Div Radiat Oncol, Dept Oncol, Edmonton, AB, Canada
[9] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada
[10] Tom Baker Canc Clin, Calgary, AB, Canada
[11] Royal Alexandra Hosp, Edmonton, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer
    Bhargava, P. G.
    Engineer, R.
    Ramaswamy, A.
    Srinivas, S. Sujay
    Shah, M.
    Agarwal, A.
    Saklani, A.
    Parulekar, M.
    Mandavkar, S.
    Ostwal, V. S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1283 - S1283
  • [2] One Versus 2 Cycles of Mitomycin C in Concurrent Chemoradiation for Treatment of Anal Canal Carcinoma: An Analysis of Outcomes and Toxicity
    Yeung, R.
    McConnell, Y.
    Roxin, G.
    Banerjee, R.
    MacLean, A. R.
    Buie, W. D.
    Mulder, K. E.
    Vickers, M. M.
    Joseph, K. J.
    Doll, C. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S351 - S351
  • [3] Politics, health, and mesothelioma: when it comes to cancer, none is one too many
    Touyz, Louis Z. G.
    [J]. CURRENT ONCOLOGY, 2012, 19 (05) : E374 - E375
  • [4] Optimising Treatment of Anal Cancer: 3D Conformal Radiotherapy with Concurrent Mitomycin C and Capecitabine
    Smith, D.
    Raouf, S.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (03) : S53 - S54
  • [5] EPIDERMOID ANAL CANCER - TREATMENT BY RADIATION ALONE OR BY RADIATION AND 5-FLUOROURACIL WITH AND WITHOUT MITOMYCIN-C
    CUMMINGS, BJ
    KEANE, TJ
    OSULLIVAN, B
    WONG, CS
    CATTON, CN
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (05): : 1115 - 1125
  • [6] IMRT AND CONCURRENT CHEMOTHERAPY FOR ANAL CANAL CANCER PATIENTS: AVOIDING TREATMENT BREAKS
    Kollar, A.
    Aebersold, D. M.
    Blumstein, N. M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 631 - 631
  • [7] COMBINED PREOPERATIVE CHEMOTHERAPY AND RADIATION IN TREATMENT OF ANAL-CANAL CANCER
    LEICHMAN, CG
    LEICHMAN, LP
    NIGRO, N
    VAITKEVICIUS, VK
    CONSIDINE, B
    BUROKER, T
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 74 - 74
  • [8] Efficacy of chemotherapy and radiation therapy treatment for anal canal cancer.
    Paik, P
    Towson, JA
    Anthone, G
    Beart, R
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 148A - 148A
  • [9] Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
    Sergey S. Gordeyev
    Arsen O. Rasulov
    Vera A. Gorbounova
    Sergey I. Tkachev
    Valeriya V. Glebovskaya
    Mikhail Yu. Fedyanin
    Nataliya S. Besova
    Yulia E. Surayeva
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 623 - 629
  • [10] Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
    Gordeyev, Sergey S.
    Rasulov, Arsen O.
    Gorbounova, Vera A.
    Tkachev, Sergey I.
    Glebovskaya, Valeriya V.
    Fedyanin, Mikhail Yu.
    Besova, Nataliya S.
    Surayeva, Yulia E.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 623 - 629
12345